Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
NeuroVive's KL1333 Receives FDA Orphan Drug Designation for Treatment of Mitochondrial Diseases 2018-04-18 15:57
NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment 2018-04-17 15:03
Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ) 2018-02-15 16:35
NeuroVive Decides on a Rights Issue for Continued Drug Development 2018-02-15 16:18
NeuroVive Reports Breakthrough in Mitochondrial Myopathy Project 2018-01-29 21:05
NeuroVive to Present at the 10th Annual Biotech Showcase Conference 2018-01-03 16:10
NeuroVive Reports Promising Progress in its Clinical Project for Genetic Mitochondrial Diseases, KL1333 2017-12-11 18:56
Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ) 2017-11-30 19:51
NeuroVive's Genetic Mitochondrial Disease Program NVP015 Reaches Significant Milestone 2017-11-30 16:26
NeuroVive Presents TBI Clinical Study Results at Nordic Neurotrauma Conference 2017-11-15 16:48
NeuroVive Board Chair Resigns, New Chair Elected 2017-11-07 15:55
NeuroVive Conducts a Directed New Share Issue of SEK 5.3 Million 2017-11-03 16:33
NeuroVive Signs Collaboration Agreement With University of Florida for TBI Biomarker Development 2017-10-31 16:32
NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research 2017-10-18 15:05
NeuroVive's Collaborator, the Children's Hospital of Philadelphia Awarded NIH Grant to Study NVP015 Against Chemical Threats 2017-10-06 05:44
NeuroVive Receives Research Grant From Vinnova for Development of the NVP015 Genetic Mitochondrial Disease Project 2017-06-01 19:52
NeuroVive Pharmaceutical AB Interim Report January - March 2017 2017-05-18 15:18
NeuroVive in-licenses a Genetic Mitochondrial Disease Clinical Stage Project From Yungjin Pharm 2017-05-02 11:51
NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects 2017-04-20 15:05
1 2